Aerska
ActiveDeveloping RNA medicines to treat, delay, and prevent diseases of the brain.
What it does
Aerska is developing systemically administered RNA interference (RNAi) medicines for diseases of the brain by leveraging an antibody-oligonucleotide conjugate platform with “brain-shuttle” delivery to cross the blood-brain barrier.
Its site says now · captured 2026-08-23
Aerska | RNA medicines for diseases of the brain
Aerska develops targeted RNA medicines to treat brain diseases. By silencing genes that cause harm, we can preserve the minds and memories of those we love.